Are stock markets about to crash hard?
Revive Therapeutics (RVV.CN) announces FDA acceptance of meeting request
Top 5 Gainers and Losers: LAC.TO, WEED.TO, OML.V
BC Bud Corp (BCBC.C) breathes new life into the cannabis space, up 3x in two months
Top 5 Gainers and Losers: TMQ.TO, GLM.CN, AGMR.V
Standard Uranium (STND.V) reports on exploration at Sun Dog Project
Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain.
Read full article here: https://equity.guru/2021/07/acorda-therapeutics-acor-q-taking-pills-in-inbrija-announces-agreement-to-commercialize-parkinsons-treatment-in-spain/
